biote Corp.

For the period ended Sep 30, 2025. Filed Nov 7, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 7, 2025

BTMD$1.08-2.7%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Stockholders’ Equity (Deficit)

Total
Accumulated · Stockholders’
Additional · Other · Deficit · Non- · Total
Class A Common Stock · Class V Voting Stock · Paid-in · Accumulated · Comprehensive · Treasury · Attributable to · controlling · Stockholders’
	Shares	Amount	Shares	Amount	Capital	Deficit	Loss	Stock	biote Corp.	Interest	Deficit
Balance at December 31, 2024	31,485,777	$3	5,221,653	$1	$—	$(100,297)	$(35)	$(5,600)	$(105,928)	$3,728	$(102,200)
Distributions	—	—	—	—	—	—	—	—	—	(694)	(694)
Net income	—	—	—	—	—	13,718	—	—	13,718	2,121	15,839
Other comprehensive income (loss)	—	—	—	—	—	—	(4)	—	(4)	—	(4)
Share-based compensation	—	—	—	—	—	2,127	—	—	2,127	—	2,127
TRA liability	—	—	—	—	—	106	—	—	106	—	106
Balance at March 31, 2025	31,485,777	$3	5,221,653	$1	$—	$(84,346)	$(39)	$(5,600)	$(89,981)	$5,155	$(84,826)
Distributions	—	—	—	—	—	—	—	—	—	(887)	(887)
Net income	—	—	—	—	—	3,185	—	—	3,185	740	3,925
Other comprehensive income (loss)	—	—	—	—	—	—	9	—	9	—	9
Share-based compensation	—	—	—	—	—	2,186	—	—	2,186	—	2,186
Vesting of RSUs	24,039	—	—	—	—	(566)	—	—	(566)	566	—
Issuance of stock under purchase plans	21,595	—	—	—	—	58	—	—	58	14	72
Exercise of stock options	64,040	—	—	—	—	(436)	—	—	(436)	662	226
Shares issued in connection with acquisition	97,276	—	—	—	—	(14)	—	—	(14)	14	—
TRA liability	—	—	—	—	—	455	—	—	455	—	455
Balance at June 30, 2025	31,692,727	$3	5,221,653	$1	$—	$(79,478)	$(30)	$(5,600)	$(85,104)	$6,264	$(78,840)
Distributions	—	—	—	—	—	—	—	—	—	(8)	(8)
Net income	—	—	—	—	—	8,188	—	—	8,188	1,028	9,216
Other comprehensive income (loss)	—	—	—	—	—	—	—	—	—	—	—
Share-based compensation	—	—	—	—	—	2,410	—	—	2,410	—	2,410
Class A common stock repurchased	(1,011,767)	—	—	—	—	—	—	(3,365)	(3,365)	—	(3,365)
Legal Settlement - Liabilities	—	—	—	—	—	6,060	—	—	6,060	—	6,060
TRA liability	—	—	—	—	—	(940)	—	—	(940)	—	(940)
Balance at September 30, 2025	30,680,960	$3	5,221,653	$1	$—	$(63,760)	$(30)	$(8,965)	$(72,751)	$7,284	$(65,467)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (DEFICIT)

Total
Accumulated · Stockholders’
Additional · Other · Deficit · Non- · Total
Class A Common Stock · Class V Voting Stock · Paid-in · Accumulated · Comprehensive · Treasury · Attributable to · controlling · Stockholders’
Shares · Amount · Shares · Amount · Capital · Deficit · Loss · Stock · biote Corp. · Interest · Deficit
Balance at December 31, 2023	34,254,883		$3		28,819,066		$3		$—		$(29,391)		$(12)		$—		$(29,397)		$(7,149)		$(36,546)
Distributions	—		—		—		—		—		—		—		—		—		(2,112)		(2,112)
Net loss	—		—		—		—		—		(4,161)		—		—		(4,161)		(1,565)		(5,726)
Other comprehensive income (loss)	—		—		—		—		—		—		(2)		—		(2)		(3)		(5)
Share-based compensation	—		—		—		—		—		1,763		—		—		1,763		—		1,763
Vesting of RSUs	177,843		—		—		—		—		(90)		—		—		(90)		90		—
Exercise of stock options	80,598		—		—		—		—		(931)		—		—		(931)		1,255		324
Class A common stock repurchased	(740,921)		—		—		—		—		—		—		(4,088)		(4,088)		—		(4,088)
Shares issued in connection with acquisition	291,829		—		—		—		—		879		—		—		879		695		1,574
Balance at March 31, 2024	34,064,232		$3		28,819,066		$3		$—		$(31,931)		$(14)		$(4,088)		$(36,027)		$(8,789)		$(44,816)
Distributions	—		—		—		—		—		—		—		—		—		(2,091)		(2,091)
Net loss	—		—		—		—		—		(7,087)		—		—		(7,087)		(3,281)		(10,368)
Other comprehensive income (loss)	—		—		—		—		—		—		(3)		—		(3)		—		(3)
Share-based compensation	—		—		—		—		—		2,841		—		—		2,841		—		2,841
Vesting of RSUs	215,190		—		—		—		—		(17,759)		(7)		—		(17,766)		17,766		—
Issuance of stock under purchase plans	35,698		—		—		—		—		(725)		—		—		(725)		871		146
Exercise of stock options	63,503		—		—		—		—		(2,549)		(1)		—		(2,550)		2,788		238
Class A common stock repurchased	(256,043)		—		—		—		—		—		—		(1,511)		(1,511)		—		(1,511)
Shares issued in connection with acquisition		—		—		—		—		267		—		—		267		—		267
Exchanges of Class V voting stock	1,946,408		—		(1,946,408)		—		—		3,656		2		—		3,658		(3,658)		—
Legal Settlement - Repurchase of Shares	(5,075,090)		—		(21,651,005)		(2)		—		(126,498)		1		(1)		(126,500)		(1,916)		(128,416)
Legal Settlement - Liabilities	—		—		—		—		—		41,424		—		—		41,424		—		41,424
TRA liability	—		—		—		—		—		829		—		—		829		—		829
Balance at June 30, 2024	30,993,898		$3		5,221,653		$1		$—		$(137,532)		$(22)		$(5,600)		$(143,150)		$1,690		$(141,460)
Distributions	—		—		—		—		—		—		—		—		—		(453)		(453)
Net income	—		—		—		—		—		10,702		—		—		10,702		1,955		12,657
Other comprehensive income (loss)	—		—		—		—		—		—		(7)		—		(7)		(1)		(8)
Share-based compensation	—		—		—		—		—		2,245		—		—		2,245		—		2,245
Vesting of RSUs	51,750		—		—		—		—		(110)		—		—		(110)		110		—
Exercise of stock options	67,015		—		—		—		—		30		(0)		—		30		217		247
TRA liability	—		—		—		—		—		(52)		—		—		(52)		—		(52)
Balance at September 30, 2024	31,112,663		$3		5,221,653		$1		$—		$(124,717)		$(29)		$(5,600)		$(130,342)		$3,518		$(126,824)

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.